Senior insider sale
Chief Executive Officer at CRESCENT BIOPHARMA, INC. — senior position signals high conviction
$944.9K
52.93K shares
What this filing means
BRUMM JOSHUA T plans to sell 52.93K shares of CRESCENT BIOPHARMA, INC. valued at approximately $944.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/17/2026ACC: 0001628280-26-062529
DirectorOfficer· Chief Executive Officer
Since Jun 2025
52.93K
Shares to sell
$944.9K
Approx. market value
16.77K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Unit Vesting
Services rendered
9/17/2026
16.77KTotal acquired16.77K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/17/2026 | Restricted Stock Unit Vesting Services rendered | 16.77K | — |
| Total | 16.77K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
1.61K
Market value
$28.8K
9/16/2026
—Completed
Units to sell
42.30K
Market value
$761.3K
6/22/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
9.01K
Market value
$154.8K
9/18/2026
Total
Units
52.93K
Value
$944.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/16/2026 | 1.61K | $28.8K | — | Completed |
6/22/2026 | 42.30K | $761.3K | — | Completed |
| Planned — Approximate Date | ||||
9/18/2026 | 9.01K | $154.8K | Nasdaq | Planned |
| Total | 52.93K | $944.9K | ||